treat most patients with late poststroke seizures. The aim of this study was to evaluate the
efficacy and tolerability of levetiracetam (LEV) in patients aged 60 or older with late-onset
poststroke seizures. This prospective study evaluated patients 60 years of age or older, who
had at least two late-onset poststroke seizures and were given LEV monotherapy.
Demographic data and seizure and stroke characteristics were recorded. Outpatient visits …